ReShape Lifesciences sells obesity devices to Biorad MedisysReShape has entered into an asset purchase agreement with Biorad Medisys, which is party to a previously disclosed exclusive license...
SURMOUNT-5: Zepbound superior to Wegovy in head-to-head trial showing an average weight loss of 20.2% vs. 13.7%4 days ago